IL17A and atherosclerosis: High concentration of IL-17A in atherosclerotic plaques can promote the development of atherosclerotic lesions [15], while blockade of IL-17A in atherosclerosis mice model resulted in a significant reduction of atherosclerotic lesions [9, 16].